Application 207202

Type: NDA
Sponsor: OTSUKA PHARM CO LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	2MG	Yes	No
002	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	5MG	Yes	Yes
003	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	10MG	Yes	No
004	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	15MG	Yes	No
005	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	20MG	Yes	No
006	ABILIFY MYCITE KIT	ARIPIPRAZOLE	TABLET;ORAL	30MG	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N207202-001	ABILIFY MYCITE KIT	ARIPIPRAZOLE	2MG	TABLET / ORAL	RLD	2017-11-13
N207202-002	ABILIFY MYCITE KIT	ARIPIPRAZOLE	5MG	TABLET / ORAL	RLD	2017-11-13
N207202-003	ABILIFY MYCITE KIT	ARIPIPRAZOLE	10MG	TABLET / ORAL	RLD	2017-11-13
N207202-004	ABILIFY MYCITE KIT	ARIPIPRAZOLE	15MG	TABLET / ORAL	RLD	2017-11-13
N207202-005	ABILIFY MYCITE KIT	ARIPIPRAZOLE	20MG	TABLET / ORAL	RLD	2017-11-13
N207202-006	ABILIFY MYCITE KIT	ARIPIPRAZOLE	30MG	TABLET / ORAL	RLD	2017-11-13

Orange Book patents#

Current patent rows page 1 of 3 · 162 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N207202-001	11476952	2026-04-28		Drug product	2022-11-09
N207202-001	9125939	2026-07-28	U-1749		2017-12-12
N207202-001	7978064	2026-09-14		Drug product	2017-12-12
N207202-001	8759350	2027-03-02	U-1529		2017-12-12
N207202-001	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-001	9119554	2028-12-16		Drug product	2017-12-12
N207202-001	9060708	2029-03-05		Drug product	2017-12-12
N207202-001	9258035	2029-03-05		Drug product	2017-12-12
N207202-001	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-001	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-001	10441194	2029-07-26		Drug product	2019-11-01
N207202-001	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-001	9433371	2029-09-15		Drug product	2017-12-12
N207202-001	8718193	2029-12-05		Drug product	2017-12-12
N207202-001	9149577	2029-12-15		Drug product	2017-12-12
N207202-001	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-001	8545402	2030-04-27		Drug product	2017-12-12
N207202-001	8114021	2030-06-21		Drug product	2017-12-12
N207202-001	11464423	2030-09-15		Drug product	2022-11-09
N207202-001	9941931	2030-11-04		Drug product	2018-05-07
N207202-001	8961412	2030-11-17		Drug product	2017-12-12
N207202-001	8258962	2030-11-25		Drug product	2017-12-12
N207202-001	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-001	11229378	2031-07-11		Drug product	2022-02-18
N207202-001	9320455	2031-12-15		Drug product	2017-12-12
N207202-001	10517507	2032-06-13		Drug product	2020-01-23
N207202-001	9268909	2033-10-15	U-2168	Drug product	2017-12-12
N207202-002	11476952	2026-04-28		Drug product	2022-11-09
N207202-002	9125939	2026-07-28	U-1749		2017-12-12
N207202-002	7978064	2026-09-14		Drug product	2017-12-12
N207202-002	8759350	2027-03-02	U-1529		2017-12-12
N207202-002	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-002	9119554	2028-12-16		Drug product	2017-12-12
N207202-002	9060708	2029-03-05		Drug product	2017-12-12
N207202-002	9258035	2029-03-05		Drug product	2017-12-12
N207202-002	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-002	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-002	10441194	2029-07-26		Drug product	2019-11-01
N207202-002	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-002	9433371	2029-09-15		Drug product	2017-12-12
N207202-002	8718193	2029-12-05		Drug product	2017-12-12
N207202-002	9149577	2029-12-15		Drug product	2017-12-12
N207202-002	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-002	8545402	2030-04-27		Drug product	2017-12-12
N207202-002	8114021	2030-06-21		Drug product	2017-12-12
N207202-002	11464423	2030-09-15		Drug product	2022-11-09
N207202-002	9941931	2030-11-04		Drug product	2018-05-07
N207202-002	8961412	2030-11-17		Drug product	2017-12-12
N207202-002	8258962	2030-11-25		Drug product	2017-12-12
N207202-002	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-002	11229378	2031-07-11		Drug product	2022-02-18
N207202-002	9320455	2031-12-15		Drug product	2017-12-12
N207202-002	10517507	2032-06-13		Drug product	2020-01-23
N207202-002	9268909	2033-10-15	U-2168	Drug product	2017-12-12
N207202-003	11476952	2026-04-28		Drug product	2022-11-09
N207202-003	9125939	2026-07-28	U-1749		2017-12-12
N207202-003	7978064	2026-09-14		Drug product	2017-12-12
N207202-003	8759350	2027-03-02	U-1529		2017-12-12
N207202-003	9444503	2027-11-19	U-2169	Drug product	2017-12-12
N207202-003	9119554	2028-12-16		Drug product	2017-12-12
N207202-003	9060708	2029-03-05		Drug product	2017-12-12
N207202-003	9258035	2029-03-05		Drug product	2017-12-12
N207202-003	8674825	2029-04-09	U-2170	Drug product	2017-12-12
N207202-003	8956288	2029-07-06	U-2167	Drug product	2017-12-12
N207202-003	10441194	2029-07-26		Drug product	2019-11-01
N207202-003	8945005	2029-08-19	U-2167	Drug product	2017-12-12
N207202-003	9433371	2029-09-15		Drug product	2017-12-12
N207202-003	8718193	2029-12-05		Drug product	2017-12-12
N207202-003	9149577	2029-12-15		Drug product	2017-12-12
N207202-003	8847766	2030-03-29	U-2167	Drug product	2017-12-12
N207202-003	8545402	2030-04-27		Drug product	2017-12-12
N207202-003	8114021	2030-06-21		Drug product	2017-12-12
N207202-003	11464423	2030-09-15		Drug product	2022-11-09
N207202-003	9941931	2030-11-04		Drug product	2018-05-07
N207202-003	8961412	2030-11-17		Drug product	2017-12-12
N207202-003	8258962	2030-11-25		Drug product	2017-12-12
N207202-003	8547248	2030-12-18	U-2167	Drug product	2017-12-12
N207202-003	11229378	2031-07-11		Drug product	2022-02-18
N207202-003	9320455	2031-12-15		Drug product	2017-12-12
N207202-003	10517507	2032-06-13		Drug product	2020-01-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-005	ABILIFY MYCITE KIT	20MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N207202-006	ABILIFY MYCITE KIT	30MG	TABLET / ORAL	RLD	2017-11-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-001	ABILIFY MYCITE KIT	2MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-002	ABILIFY MYCITE KIT	5MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-003	ABILIFY MYCITE KIT	10MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N207202-004	ABILIFY MYCITE KIT	15MG	TABLET / ORAL	RLD	2017-11-13	`b8a1b40f171c…`

Observed Orange Book patent history#

Patent history page 1 of 197 · 7,854 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N207202-001	11476952	2026-04-28		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9125939	2026-07-28	U-1749		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	7978064	2026-09-14		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8759350	2027-03-02	U-1529		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9444503	2027-11-19	U-2169	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9119554	2028-12-16		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9060708	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9258035	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8674825	2029-04-09	U-2170	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8956288	2029-07-06	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	10441194	2029-07-26		Drug product	2019-11-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8945005	2029-08-19	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9433371	2029-09-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8718193	2029-12-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9149577	2029-12-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8847766	2030-03-29	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8545402	2030-04-27		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8114021	2030-06-21		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	11464423	2030-09-15		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9941931	2030-11-04		Drug product	2018-05-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8961412	2030-11-17		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8258962	2030-11-25		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	8547248	2030-12-18	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	11229378	2031-07-11		Drug product	2022-02-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9320455	2031-12-15		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	10517507	2032-06-13		Drug product	2020-01-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-001	9268909	2033-10-15	U-2168	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	11476952	2026-04-28		Drug product	2022-11-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9125939	2026-07-28	U-1749		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	7978064	2026-09-14		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8759350	2027-03-02	U-1529		2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9444503	2027-11-19	U-2169	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9119554	2028-12-16		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9060708	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9258035	2029-03-05		Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8674825	2029-04-09	U-2170	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8956288	2029-07-06	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	10441194	2029-07-26		Drug product	2019-11-01	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	8945005	2029-08-19	U-2167	Drug product	2017-12-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N207202-002	9433371	2029-09-15		Drug product	2017-12-12	`84e616aacf4f…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N207202-001	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-002	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-003	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-004	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-005	I-746	2020-07-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N207202-006	I-746	2020-07-27	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N207202-001	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-002	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-003	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-004	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-005	I-746	2020-07-27	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N207202-006	I-746	2020-07-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N207202-001	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-002	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-003	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-004	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-005	I-746	2020-07-27	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N207202-006	I-746	2020-07-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N207202-001	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-002	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-003	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-004	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-005	I-746	2020-07-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N207202-006	I-746	2020-07-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N207202-001	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-002	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-003	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-004	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-005	I-746	2020-07-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N207202-006	I-746	2020-07-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N207202-001	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-002	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-003	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-004	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-005	I-746	2020-07-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N207202-006	I-746	2020-07-27	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 116 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Aripiprazole	ARIPIPRAZOLE	NorthStar RxLLC	f87dbfe4-5417-47c9-a97f-d246cfc10023	2023-08-30	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	SQUARE PHARMACEUTICALS LIMITED	0f9b1fd8-a648-45c9-8655-14de07439f34	2023-07-02		Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	XLCare Pharmaceuticals, Inc.	0a6fa113-6bb2-4f88-af07-ce0914c98ff2	2023-06-16	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	ScieGen Pharmaceuticals Inc	a7d9d5d1-25ba-4f4e-a990-398c0bf09c7e	2023-02-20	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Alembic Pharmaceuticals Limited	4f1691a8-724e-430d-9bab-27b59ef9bd4e	2023-01-27	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Alembic Pharmaceuticals Limited	793fc904-2f11-4f97-a0ac-4d6910cac0f9	2023-01-27	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	XLCare Pharmaceuticals, Inc.	b284b294-40a0-4ccd-b7b7-b61267cd4e76	2023-01-16	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
ARIPIPRAZOLE	ARIPIPRAZOLE	A-S Medication Solutions	aaf7dc7e-04f3-442b-86d7-5f54d17d102c	2022-09-12	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	NCS HealthCare of KY, LLC dba Vangard Labs	8da99c93-613e-4b78-9f91-3efc2dea194d	2022-08-02	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Proficient Rx LP	19a3c2f2-11eb-4ec9-ac38-134168bdf99c	2022-08-01	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Proficient Rx LP	11202c0a-7401-41c9-b1e7-d93739fcd36f	2022-06-01	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Dr.Reddys Laboratories Inc	0aa7e178-456a-4942-93aa-9ec18a58939f	2020-06-16	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	ScieGen Pharmaceuticals Inc	95954ba3-e838-4dd7-aef1-c51ac6aff76b	2020-05-06	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Proficient Rx LP	dbdc8fbe-c75f-4f17-a2cd-9f23802dcc5d	2019-11-01	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
Aripiprazole	ARIPIPRAZOLE	Exelan Pharmaceuticals, Inc.	705190bf-9f9d-4183-a56b-4eeafeacde59	2018-12-28	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE
ARIPIPRAZOLE	ARIPIPRAZOLE	Camber Pharmaceuticals, Inc.	3718e585-06b9-40fd-a3eb-18b6497a4235	2017-08-08	Boxed warning, Warnings, Adverse reactions	Name fallback generic name: ARIPIPRAZOLE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 42 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-029	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-030	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-031	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-032	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-033	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceut	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current
59148-034	Abilify MyCite	ARIPIPRAZOLE	Otsuka America Pharmaceutical, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
81138	SUPPL	2025-02-07
81020	SUPPL	2025-02-05
81019	SUPPL	2025-02-05
72782	SUPPL	2022-12-05
72781	SUPPL	2022-12-05
72757	SUPPL	2022-12-01
65741	SUPPL	2020-12-28
65740	SUPPL	2020-12-28
61815	SUPPL	2020-02-06
61813	SUPPL	2020-02-06
61812	SUPPL	2020-02-06
61811	SUPPL	2020-02-06
61795	SUPPL	2020-02-06
61794	SUPPL	2020-02-06
55134	ORIG	2018-08-08
50415	ORIG	2017-11-15
50398	ORIG	2017-11-13